Brief: Heidelberg Pharma Secures Financing From Main Shareholder Dievini
Jan 22 (Reuters) - HEIDELBERG PHARMA AG WL6G.DE :
* SECURES FINANCING COMMITMENT FROM ITS MAIN SHAREHOLDER
DIEVINI
* DIEVINI WILL PROVIDE COMPANY WITH UP TO EUR 15 MILLION.
* WITH THIS ADDITIONAL COMMITMENT, COMPANY'S CASH REACH IS
SECURED
UNTIL MID-2021
* DETAILED FORM OF FINANCING WILL BE DECIDED BY MANAGEMENT
AND
SUPERVISORY BOARDS OF HEIDELBERG PHARMA AG
Source text for Eikon: ID:nEQ7bVBHXa
Further company coverage: WL6G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty